Biosimilars Market Report

Take Up Global Biosimilars Market Opportunities With Clear Industry Data – Includes Biosimilars Market Size

The Business Research Company’s report goes into great detail on the biosimilars market size and growth, biosimilars market regional analysis, biosimilars market competitive landscape, and other critical information needed to excel in the biosimilars industry.


Major players in the biosimilars market include Amgen, Pfizer, Novartis AG, Viatris, Samsung Bioepis Co., Ltd.


TBRC’s comprehensive market report based on extensive research will assist you in seamlessly devising your approaches in order to match key market player strategies.


The biosimilars market is expected to grow from $11.41 billion in 2021 to $25.98 billion in 2026 at a rate of 17.3%. The market is then expected to grow at a CAGR of 18.0% from 2026 and reach $59.55 billion in 2031.


Western Europe was the largest region in the global biosimilars market, accounting for 71.06% of the total in 2021.


The biosimilars market consists of sales of biosimilars and related services that are used to treat chronic diseases such as diabetes, arthritis, and cancer. Biosimilars are pharmaceuticals that are proteins and are expressed in mammalian cell lines using cell lines and have been shown to offer no clinical difference compared to approved biologics. Biosimilars are made once the patent of the original biologic has expired.


High penetration of the biologics is expected to be a driver of market growth during this period. Pharmaceutical companies are shifting towards originator biologics and competitive biosimilar drug development.


Request a Sample of the Biosimilars Market Report


Biosimilars Market Report
Biosimilars Market Report


The increasing adoption and use of robotics and artificial intelligence (AI) are key trends gaining popularity in the biosimilars market. Artificial intelligence is intelligence demonstrated by machines and is highly versatile.


TBRC’s global biosimilars market report is segmented:
By Type: Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Others

By Application: Oncology, Chronic and Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Others

By Geography: North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.


The Biosimilars Market Report 2022 is one of a series of new reports from The Business Research Company that provides an overview of the biosimilars market globally and regionally, analyzes and forecasts market size, share, biosimilars market players, biosimilars market segments, leading competitor revenues, profiles and market shares.


Here Is A List Of Similar Reports From The Business Research Company:

Biosimilar Monoclonal Antibodies Global Market Report 2022

Rituximab Biosimilars Global Market Report 2022

Biosimilar Lymphocyte Modulator Global Market Report 2022


Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.


Read more about us at


Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn:
Follow us on Twitter:
Check out our Global Market Model:

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *